Metabolic Effects of JAK1/2 Inhibition in Patients with Myeloproliferative Neoplasms
Source: Sapre M, Tremblay D, Leiter A, et al. SAT-091 Metabolic Effects of JAK1/2 Inhibition in Patients with Myeloproliferative Neoplasms. Journal of the Endocrine Society, Volume 3, Issue Supplement 1, April-May 2019. DOI: 10.1210/js.2019-SAT-091
Published
Join OnMedica and benefit from:
- Bitesize CPD and easy to digest content, free for UK-based GPs and specialist doctors
- High-quality, evidence-based content developed by expert editors and clinicians
- Articles, quizzes, videos, visual summaries and more
- Regulatory alerts and round-up of medical journals
- New content added daily, so you know you’re always up to date
